CLARITO VILLANUEVA: Open Payments
NPI 1770148603 · SANTA CLARITA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 41 payments from 13 companies in 2025. Trend: 2023 $724 · 2024 $795 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| E.R. Squibb & Sons, L.L.C. | 5 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $138 |
| Vanda Pharmaceuticals Inc. | 3 | $96 |
| ABBVIE INC. | 5 | $95 |
| Alkermes, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Lundbeck LLC | 1 | $25 |
| Corium, LLC | 1 | $24 |
Products named: COBENFY, CAPLYTA, VRAYLAR, REXULTI, FANAPT, TRINTELLIX, Qelbree, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
